Introduction
In vitro embryo production has emerged as a better alternative to the in vivo embryo production technique for large-scale production of embryos to be used for assisted reproductive technologies. The reduced developmental competence of oocytes collected from abattoir ovaries limits the suitability of these oocytes for reproductive biotechnology research and retards the application of in vitro embryo production for commercial embryo technology.
During epididymal transit, sperms acquire the ability to move progressively; however, they are still incompetent in terms of fertilization (1) . Fertilization capacity is gained after the sperm cells reside in the female reproductive tract for a definite period of time. In the female genital tract, mammalian spermatozoa undergo a unique maturational change, i.e. capacitation (2) . Capacitation encompasses several cellular changes in the sperm, particularly in the distribution and composition of certain glycoproteins, protein tyrosine phosphorylation, and intracellular Ca 2+ and cAMP concentrations, as well as motility patterns (3) . This phenomenon is an absolute prerequisite that spermatozoa must undergo in order to interact efficiently with the zona pellucida and to accomplish one of the last steps leading to fertilization, namely the acrosome reaction. Thus, capacitation is a critical biological process in spermatozoa to acquire the ability to fertilize the in vitro matured oocytes. It has been reported that chemically defined media with different capacitating agents, i.e. heparin, calcium ionophore, and caffeine (4) (5) (6) (7) (8) (9) , are able to induce capacitation of spermatozoa used for in vitro fertilization.
In vitro fertilization rates may be variable, depending upon the capacitating agent and concentration used. Therefore, efforts have to be made to standardize the semen capacitating process to improve the quality and quantity of in vitro-produced embryos. Selection of the capacitating agent, its concentration, and exposure time may play an important role in in vitro fertilization and subsequent in vitro embryo development. To date, meager attempts have been made to understand the dose-dependent effect of capacitating agents in small ruminants. Realizing the importance of this technology, the present study was carried out comparing different capacitating agents, doses of capacitating agents, and capacitation times to assess the impact of sperm pretreatment on in vitro fertilization and embryo developmental competence of caprine oocytes.
Materials and methods
All experimental procedures under study were undertaken according to the guidelines approved by the institutional animal ethics committee. All chemicals used were procured from Sigma Chemical Co. (St. Louis, MO, USA).
Collection and processing of ovaries
Caprine ovaries were obtained from a local slaughter house and transported to the laboratory in a thermos flask containing 0.9% sterile warm physiological normal saline solution supplemented with antibiotics. All the ovaries were then subjected to 5 or 6 serial washings with warm saline fortified with antibiotics and brought into a laminar flow for processing.
Oocyte collection and in vitro maturation
The oocytes were collected from each ovary into a petri plate containing oocyte collection media (Dulbecco's phosphate-buffered saline with 3 mg/mL BSA) by follicle puncture method with the help of a B.P. blade. Each petri dish containing oocytes was evaluated under a stereo zoom microscope and grade A, B, and C oocytes were chosen for in vitro maturation as per the method described by Kharche et al. (10) . Selected oocytes were washed four or five times in oocyte holding medium (OHM-TCM-199 with HEPES modification, FBS 10%, sodium pyruvate 0.25 mM, gentamycin 50 µg/mL, glutamine 100 µg/mL, BSA 3 mg/mL). The oocytes were then washed three times with oocyte maturation medium and matured as per the method described by Kharche et al. (10) .
Semen collection and in vitro capacitation
Semen ejaculate was collected from a fertile buck using an artificial vagina. Immediately after semen collection, ejaculate was assessed in terms of volume, color, consistency, and progressive and gross motility at a total magnification of 200 ×. Calcium ionophore A23187 (Sigma Chemical Co.) stock solution was prepared as stock in dimethyl sulfoxide and was frozen at -20 °C. Before use this was thawed and diluted with modified Tyrode's medium (TALP) as described by Parrish et al. (6) to make final concentrations of 0.1, 0.2, and 0.5 µmol. Similarly, heparin (Sigma Chemical Co.) stock solution was prepared as stock in ultrapure water (Sigma Chemical Co.) and frozen at -20 °C. Before use this was thawed and supplemented with modified TALP as described by Parrish et al. (6) to make final concentrations of 20 and 50 µL/ mL. The medium stock was prepared every week and was sterilized by Millipore filtration (pore size of 0.22 μm). The method of sperm pretreatment and in vitro fertilization was followed based on methodology described by Singh et al. (11) with minor modifications. First, 100 µL of semen ejaculate was diluted with 5 mL of sperm TALP medium and centrifuged at 1200 rpm for 5 min. The supernatant was discarded and the sperm pellet was resuspended in the same medium. This step was repeated three times to remove all seminal plasma. After a final washing, 50 µL of sperm pellet from each group was added to 900 µL of each group of fertilization medium (TALP solution containing 10% FBS, 8 mg/mL fatty acid-free BSA) with different doses of capacitating agents. The first experiment was conducted to assess the dose-dependent effect of heparin in sperm pretreatment for two different incubation periods (30 and 60 min) on in vitro embryo development potential. In experiment 1, sperms were capacitated as follows: Group 1, heparin 20 µg/mL for 30 min; Group 2, heparin 50 µg/ mL for 30 min; Group 3, heparin 20 µg/mL for 60 min; Group 4, heparin 50 µg/mL for 60 min; Group 5 (control), heparin 0.0 µg/mL for 60 min.
Based on the results of the first experiment on incubation period, the second experiment was carried out to study the dose-dependent effect of calcium ionophore for 60 min of incubation for sperm pretreatment during in vitro fertilization. Experiment 2 investigated the effect of 60 min of calcium ionophore exposure at different concentrations (0, 0.1, 0.2, and 0.5 µM) on sperm pretreatment/capacitation. Sperm pellets were divided into four groups and capacitated as follows: Group 1, calcium ionophore (0.1 µM); Group 2, calcium ionophore (0.2 µM); Group 3, calcium ionophore (0.5 µM); Group 4 (control), calcium ionophore (0.0 µM) for 60 min. The third experiment was carried out based on the first two experiments to validate and compare the effect of the two different capacitating agents with optimum dose on sperm pretreatment for capacitation during in vitro fertilization as estimated in experiments 1 and 2 on sperm pretreatment. Sperm pretreatment was done for 60 min in fertilization TALP medium containing capacitating agents as follows: Group 1, heparin (20 µg/mL); Group 2, calcium ionophore (0.1 µM); Group 3, control (without any capacitating agent) in humidified atmosphere of 5% CO 2 at 38.5 ± 1 °C in a CO 2 incubator.
In vitro fertilization
After 27 h of in vitro maturation, oocytes were denuded in 0.1% hyaluronidase and passed repeatedly through a fine pipette for 3-5 min. After 27 h of culture, oocytes were evaluated for cumulus expansion and the presence of a first polar body. Only the mature oocytes were picked up and denuded in 0.1% hyaluronidase by repeated pipetting through a fine pipette for 3-5 min. The denuded oocytes were washed 5 or 6 times in a fert-TALP medium and then transferred into drops of fert-TALP medium (50 µL) under sterile mineral oil equilibrated for 2 h at 38.5 ± 1 °C in a CO 2 incubator. At the time of sperm insemination, 25 µL of fertilization medium was removed from preincubated fertilization drops containing matured oocytes, and 25 µL of capacitated semen from different groups was inseminated into each fertilization drop containing mature oocytes with denuded cumulus cell mass for 18 h under humidified atmosphere of 5% CO 2 at 38.5 ± 1 °C in a CO 2 incubator.
In vitro embryo culture
Eighteen hours after the insemination, presumptive zygotes were washed in order to separate adhering sperm cells. Presumptive zygotes from different groups were cultured in embryo development medium (mCR 2 aa medium containing 10% FBS and 3 mg/mL BSA) for 8-10 days in humidified atmosphere of 5% CO 2 at 38.5 ± 1 °C in a CO 2 incubator.
Evaluation of in vitro embryo development
Presumptive zygotes were observed for embryo development and half of the culture medium was replenished with fresh medium at intervals up to 12 days. Embryos were morphologically evaluated under an inverted phase contrast microscope (TE 2000, Nikon, Japan).
Statistical analysis
All data were subjected to statistical analysis using the chisquare test (χ 2 ). Cleavage rates and embryo development between treatment groups were compared using the chisquare test. A probability of P < 0.05 was considered to be statistically significant (12) .
Results
In the present study, the dose-dependent effect of different capacitating agents on cleavage rate and in vitro embryo development with special reference to blastocyst production was evaluated, validated, and compared. A total of 2795 oocytes from 1104 ovaries were recovered by follicle puncture technique, resulting in an average recovery rate of 2.53 culturable oocytes per ovary. Three independent experiments were conducted to assess the effect of sperm pretreatment on in vitro embryo development potential.
Dose-dependent effect of heparin with respect to different sperm incubation periods during in vitro fertilization
In the control group, no cleavage was observed; therefore, embryo development was not studied in this group. In experiment 1, the dose-dependent effect of heparin (0, 20, and 50 µg/mL) with respect to two different sperm incubation times (30 and 60 min) was evaluated and summarized (Table 1) . Cleavage rate differed significantly among treated groups and was significantly higher (49.46%, P < 0.05) in the sperm pretreatment group with 20 µg/mL concentration of heparin for 60 min compared to the rest of groups. Similarly, blastocyst production among treated groups was significantly higher (11.68%, P < 0.05) in the sperm pretreatment group with 20 µg/mL concentration of heparin for 60 min compared to the rest of groups. Significantly (P < 0.05) higher morula production rate was also observed in the group treated with heparin (20 µg/mL) for 60 min compared to the groups treated with heparin (50 µg/mL) for 30 min and heparin (50 µg/mL) for 60 min. Findings indicate that a lower concentration of heparin (20 µg/mL) for a longer duration (60 min) favored blastocyst production (P < 0.05) as compared to a higher concentration of heparin (50 µg/mL) for a shorter duration (30 min). Based on the experiment, treatment of oocytes with heparin at 20 µg/mL for 60 min favored a higher percentage (P < 0.05) of blastocyst production in comparison to the rest of the groups. Results obtained from this protocol were used for its validation and confirmation in experiment 3.
Effects of different concentrations of calcium ionophore during in vitro fertilization
In the control group, no cleavage was observed; therefore, embryo development was not studied in this group. In experiment 2, the dose-dependent effect of different concentrations of calcium ionophore (0, 0.1, 0.2, and 0.5 µM) on sperm pretreatment was evaluated and summarized ( Table 2 ). The cleavage rate was significantly higher (P < 0.05) with calcium ionophore at 0.2 µM as compared to other treated groups. A nonsignificant difference in the blastocyst formation rate was observed between groups treated with 0.1 and 0.2 µM calcium ionophore; numerically, more blastocyst formation was observed in sperm treated with 0.1 µM calcium ionophore. The study revealed a significantly lower percentage (P < 0.05) of 8-16-cell embryo arrest and higher morula production rates in the group treated with calcium ionophore (0.1 µM) compared to the other groups. Results obtained from this protocol were used for its validation and confirmation in experiment 3. 3.3. Validation and comparison of optimum dose of capacitating agents used in experiments 1 and 2 on sperm pretreatment during in vitro fertilization on blastocyst production In the control group, no cleavage was observed; therefore, embryo development was not studied in this group. In experiment 3, the comparative efficacy of different capacitating agents with optimum doses of heparin (20 µg/mL) and calcium ionophore (0.1 µM) on sperm pretreatment for capacitation was evaluated (Table 3) . Cleavage rate did not differ significantly between the calcium ionophore and heparin treatment groups (P > 0.05). However, blastocyst production was significantly higher (P < 0.05) in the heparin-treated group compared to the calcium ionophore-treated group.
Discussion
Capacitation is a crucial biological process that mammalian sperm must undergo in order to achieve fertilizing ability. Glycosaminoglycans, normally present in the oviductal fluid, have been regarded as potential in vivo capacitating agents (13) . Proposed mechanisms of the induction of acrosome reactions by glycosaminoglycans are those of stimulation of passive or active calcium ion influx, or direct promotion of membrane fusion by other mechanisms (14) . Calcium ionophore, heparin, caffeine, and other glycosaminoglycans are known to enhance this process (5) (6) (7) 9) . Spermatozoa of fresh semen require a period of incubation to induce the capacitation by complex transmembrane and intracellular signaling pathways. The present studies compared the effects of different sperm pretreatments, which are key determinants of efficiency of in vitro embryo production. Heparin is often added to fertilization medium to induce capacitation in vitro using different concentrations ranging from 2 to 100 µg/mL (8, 9, 15, 16) . Addition of heparin at optimized concentration during sperm incubation for 15 min (15), 30 min (7), 45 min (15, 17) , and 60 min (4) was adequate for in vitro capacitation. The present study assessed and correlated the dosedependent effects of different capacitating agents for two different incubation periods on sperm pretreatment to improve cleavage rate and blastocyst production in goats. In experiment 1, the dose-dependent effect of heparin (0, 20, and 50 µg/mL) for two different periods (30 min and 60 min) of sperm incubation was evaluated. Pretreatment of sperms with heparin for different periods of incubation revealed significantly different cleavage and embryo development rates. Statistical analysis revealed a significantly higher (P < 0.05) cleavage rate in sperm pretreatment with 60 min of incubation time in comparison to 30 min of incubation time for capacitation. Similarly, morula production was significantly higher (P < 0.05) with 20 µg/mL heparin for 60 min as compared to 50 µg/mL heparin for 30 min. Significantly higher (P < 0.05) blastocyst formation rate was observed in the sperm group treated with 20 µg/mL heparin compared to the sperm group treated with 50 µg/mL heparin for 60 min of incubation. This is consistent with the results of IVF studies stating that proper adjustment of both heparin concentration and sperm incubation time is crucial in the fertilization medium (6, 18, 19) . The present findings are in agreement with an earlier report showing that sperm pretreatment with heparin for 15 min of exposure lowered the cleavage rate and in vitro development of embryos (20) . The present findings also revealed no cleavage in the sperm pretreatment group with 0.0 µg/mL heparin (control), while oocytes were found to have cleaved in the sperm group pretreated with heparin. Similar to the present findings, heparin treatment of sperms improved cleavage and blastocyst rates compared to sperm not treated with heparin with unsorted sperm (21) . Collectively, the present study revealed significantly higher (P < 0.05) cleavage and morulae in the 20 µg/mL heparin-treated group compared to 50 µg/mL heparin treatments for 60 min of incubation time. Results indicated that 60 min of incubation for sperm pretreatment is required for obtaining an efficient cleavage rate and in vitro embryo development. This indicates that pre incubation may facilitate the process of capacitation. An earlier report also concluded that capacitation and the acrosome reaction of a portion of the sperm population can be induced within 60 min in medium with caffeine and heparin (22) . Similarly, Zhou et al. (23) treated goat sperm with 50 µg/mL heparin for 0, 10, 20, 30, 45, 60, or 120 min. Although heparin treatments for 45 to 120 min did not differ significantly (P > 0.05) in capacitated sperm percentages, sperm motility and membrane integrity decreased significantly when sperm was treated with heparin for 120 min. They suggested that the optimal exposure time of heparin at 50 µg/mL for goat sperm capacitation could be 45 to 60 min. They also compared the effect of different doses (5, 10, 25, 50, and 100 µg/mL) of heparin treatment on acrosome reaction and suggested that the optimal dose of heparin could be 50 µg/mL for goat sperm capacitation. Other evidence also supports an efficient cleavage rate and blastocyst production yield in sperm pretreatment groups with 50 µg/mL of heparin (4, 16) .
Evaluation of the dose-dependent effect of capacitating agents on in vitro embryo development demonstrated that sperm pretreatment with 20 µg/mL heparin significantly enhances cleavage and blastocyst production rate compared to 50 µg/mL heparin under in vitro conditions. This may be due to the fact that a higher concentration of heparin might increase the chances of polyspermy. Possible effects of polyspermy may lead to reduced cleavage rate and in vitro embryo development potential. Evidence also supports efficient cleavage rate and blastocyst production yield in sperm pretreatment with 50 µg/mL heparin (4, 15, 23) . Similar to the present study, Shi (18) found a significant increase in embryo yield when the heparin concentration was greater than 18 µg/mL. The present study observed no cleavage in a sperm pretreatment group with 0 µg/mL heparin, favorably supported by Shi (18) .
Calcium ionophore A23187 has been shown to induce the acrosome reaction in mammalian spermatozoa (4) . During this process acrosomal enzymes (hyaluronidase and acrosin) and motility of sperms are responsible for digestion of the ZP matrix. Once the two meet, a calcium influx occurs, causing a signaling cascade. This facilitates the penetration of the ovum and fertilization. Optimizing the dose of calcium ionophore during sperm preparation could be beneficial for sperm treatment. Experiment 2 was conducted to determine the optimal concentration of calcium ionophore for sperm pretreatment for capacitation during in vitro fertilization. Beneficial effects of calcium ionophore on sperm pretreatment are seen in the present study. The present study revealed a significantly higher cleavage rate in oocytes fertilized with sperm pretreated with calcium ionophore compared to the control. Possibly, however, the better IVF results from calcium ionophore treatment may be related to the involvement of calcium ionophore A23187 and caffeine in the IVF medium. Spermatozoa undergo an acrosomal reaction when exposed to ionophore A23187, which increases intracellular calcium (24) . The present findings are in agreement with those of Tanphaichitr and Hansen (25) . They observed higher percentages of acrosome-free spermatozoa in A23187-treated samples in comparison to control samples incubated in culture medium only (25) .
The cleavage rate following pretreatment of sperm with 0.2 µM calcium ionophore was significantly higher (P < 0.05) compared to 0.1 µM. However, in the present study, significantly higher (P < 0.05) morula production was observed in oocytes fertilized with sperms pretreated with 0.1 µM calcium ionophore. Similarly, numerically more cleaved oocytes reached the blastocyst stage in the sperm group treated with 0.1 µM calcium ionophore. However, no significant difference was observed in blastocyst production between 0.1 and 0.2 µM calcium ionophore concentrations. From the present findings it could be suggested that with increasing doses (0.1 µM to 0.2 µM) of calcium ionophore, embryo development potential decreases (Table 2) . Earlier reports also support the present findings (4, 26) .
Treatment with calcium ionophore A23187 induces an increase in intracellular calcium and increased intracellular calcium has been functionally linked to sperm capacitation (5) . As a result of their hydrophobic characteristics, calcium ionophores are able to transport ions across membranes. The increase in free calcium ionophore within the cell directly induces the acrosome reaction and leads to capacitation (19) . Several researchers also reported beneficial effects of calcium ionophore treatment on in vitro fertilization, cleavage, and subsequent embryo development competence (27, 28) . In the present study fertilized oocytes did not cleave in the sperm pretreatment group containing 0.5 µM calcium ionophore, which suggested that a higher concentration (0.5 µM) of calcium ionophore has detrimental effects on cleavage rate and subsequent embryo development. The results suggest that calcium ionophore (0.1 µM) is effective for sperm pretreatment to induce capacitation during in vitro fertilization and subsequent in vitro development. Wang et al. (26) found higher cleavage, morula, and blastocyst production rates in sperm treatment with 0.1 µM of calcium ionophore+caffeine as compared to another sperm treatment (with 5% ewe estrous serum).
Finally, based on the results of experiments 1 and 2, a third experiment was conducted to validate and compare the optimum dose of heparin and calcium ionophore for sperm pretreatment during in vitro fertilization. Different capacitating agents were used in assisted reproductive technology to induce capacitation. In this study no significant difference (P > 0.05) was observed in the cleavage, 2-cell, 4-cell, and morula production rates between the heparin-and calcium ionophore-treated groups. Heparin apparently binds to sperm and plays a role in the sperm uptake of calcium (13) . Other than heparin, calcium ionophore by passes calcium-dependent regulatory mechanisms by prompting a massive influx of calcium ions (29) . However, significantly more embryos (P < 0.05) were arrested at the 8-16-cell stage in the calcium ionophore-treated group as compared to the heparintreated group. Thus, the heparin group with an optimized concentration of 20 µg/mL was found superior to the calcium ionophore-treated group for an incubation period of 60 min. The present study revealed significantly higher (P < 0.05) blastocyst production in the heparin-treated group than the calcium ionophore-treated group. This may be due to an inadequate massive influx of calcium ions during sperm treatment with calcium ionophore. Pereira et al. (27) evaluated the effect of heparin (5 IU), caffeine (5 mM), and calcium ionophore A23187 (0.1 mM) on motility and in vitro induction of the acrosome reaction in frozen-thawed bull and goat semen. Contrary to the present findings, Pereira et al. (27) demonstrated that the treatment of semen with calcium ionophore resulted in a significantly improved percentage of live spermatozoa with true acrosome reaction at all stages of incubation, both in bovines and caprines. The possible explanation behind this could be the different concentrations of capacitating agent, incubation periods, and frozen semen used in their study. Our results are in agreement with earlier studies that indicated that heparin may not only influence the fertilization process but may also affect subsequent embryo development (21, 30) .
The results of the present study led to the conclusions that supplementation of heparin (with 20 µg/mL concentration for 60 min of incubation) in fertilization medium significantly increased (P < 0.05) the cleavage rate and blastocyst production as compared to other treated groups following in vitro fertilization by enhancing the sperm capacitation; sperm pretreatment with calcium ionophore was associated with a lower viability of embryos and blastocyst production; a higher concentration of calcium ionophore (0.1 µM concentration vs. 0.2 µM calcium ionophore) has detrimental effects on cleavage rate and subsequent embryo development as, with increasing doses of calcium ionophore, morula and blastocyst production decreases; and sperm pretreatment with 20 µg/mL heparin was found superior in terms of blastocyst production compared to calcium ionophore treatment for an incubation period of 60 min. Hence, heparin can be used to enhance capacitation of freshly collected sperms during in vitro fertilization and subsequent embryo development.
